Osseointegration is a result of cellular migration, differentiation
INTRODUCTION
The main objective of implant insertion is to achieve a structural and functional integration of the implant in the site where it is inserted keeping aesthetic criteria at the same time. The process in establishing the structural and functional integration of the implant is osseointegration. Osseointegration is a morphological and functional relationship between bone and the surface of a dental implant. This physiological state can be formed and maintained only if the implantologist is fully aware of basic biological principles including the fact that bone is dynamic tissue, an organ, and a system. This should also include understanding basic principles of cell damaging, inflammation, bone healing, bone formation and remodelling, as well as physical properties of the implant and its surface. Failing to understand these principles leads to a failure in osseointegration. As a result, the implant is surrounded by disfunctional fibrous tissue (Sumiya et al., 1989) .
Insertion of endosseus implants directly in the extraction alveolus was first introduced in the work of Schulte et al. (1979) . Today, it is one of the most important alternatives in treatment of edentulousm. There are several different classifications of protocols for inserting dental implants in the extraction alveolus. A more clear definition of types of dental implant insertion following tooth extraction should be based on morphological and histological changes that follow tooth extraction. According to Hammerle et al. (2004) there are four protocols for placing implants in the extraction alveolus.
• Implant insertion in the alveolus immediately after tooth extraction (immediate insertion);
• Implant insertion after covering the alveolus with soft tissue (typically 4-8 weeks after extraction);
• Implant insertion in the alveolus after it has been considerably filled with bone tissue, which typically happens 12-16 weeks after tooth extraction;
• Implant insertion in the extraction alveolus with both bone and soft tissue having completely healed; this is usually the case 16 weeks after extraction.
Basic preconditions for successful bone healing are the same in both immediate and delayed implant insertion, regardless of whether it is insertion into the extraction alveolus or into an already healed alveolar ridge. It is important to note that, in the case of insertion into the extraction alveolus, there is a certain gap between the surface of an implant and the alveolar wall. This gap has to be filled with bone tissue so that osseointegration can take place. Bone healing depends on the stability of the initially formed coagulum in this area. Experimental studies on animals showed that critical factors in the stabilization of the coagulum are the distance between the bone and the implant and characteristics of the implant surface (Knox et al., 1991; Stentz et al., 1997; Akimoto et al., 1999; Botticelli et al., 2003) . The absence of intact alveolar walls can have a negative influence on the stability of the blood coagulum and bone formation. To achieve bone regeneration and implant osseointegration in this case a technique of guided tissue regeneration should be applied (Gher et al., 1994; Akimoto et al., 1999) .
Guided tissue regeneration in implantology is a method based on separating bone from soft tissues using membranes, which creates a gap that is to be filled with new bone tissue that is formed (Hockers, 1999) . Numerous researches showed its efficacy in achieving filling up of bone defects which surround dental implants (Dahlin et al., 1991; Buser et al., 1990; Jovanovic et al., 1992) .
Platelet-rich plasma (PRP) is a concentrate of platelets in a small volume of plasma which can be produced of the patient's blood with a centrifuge in a blood bank, or in a preoperative process in a dentist's surgery. Growth factors that can be found in the granules of platelets are a part of PRP. They are released when the platelets are activated by initiating healing (Marx et al. 1998 .; Marx et al., 2005; Anitua, 1999; Sonnleitner et al., 2000) . Since it is simple for use and easily available, plasma rich with concentrated platelets has become the most frequently used source of growth factors in implantology in the last two years, aiming at establishing as a wide contact surface between bone and implant as possible, which provides:
-improved stability of the implant, -functional loading of the implant in a shorter time.
Growth factors that PRP contains relevant for bone regeneration are: 1) platelet derived growth factor (PDGF), and 2) transforming growth factor (TGF-beta).
The aim of the research was to clinically test the influence that PRP and guided tissue regeneration in bone defects have on dental implant stability with early insertion.
MATERIALS AND METODS
The experimental research was conducted in three phases. It was done on 10 adult dogs, following all ethical principles imposed by the MMI act no. 282-12 issued on 02/11/2002.
First phase of the experiment Doses of 0.03 mL/kg of Combelen intravenously and 0.01 mg/kg of body mass of atropine subcutaneously were used as pre-medication. Fifteen minutes after pre-medication a dose of 0.3 mL/kg of body mass of Ketamine chloride 5% was injected intramuscularly.
During the short intravenous anaesthesia the third and the fourth premolar on the both sides of the lower jaw were extracted. The extraction was done so that dental implants could be inserted in the positions of the third and the fourth premolar once the extraction injuries have healed. The extraction wounds were closed with a separate surgical closure (Dexon 3.0, Davis & Gack). A period of 8 weeks is considered to be sufficient for bone healing to take place, since the rate of bone healing for dogs is somewhat higher than for the human population.
All experimental animals were given intravenously an antibiotic (Jugocilin 1600000 i.u.). 12 hours after extraction the dogs were given food and water. They were fed with stew and kept in specially made boxes of prochrome that are easy to keep clean and disinfected. The dogs were housed at the Institute for Medical Research with conditioned air humidity and temperature of 21 o C.
Second phase of the experiment 8 weeks after the extraction of the third and the fourth premolar on both sides of the lower jaw. Blood samples were taken from the animals using 3 sterile test tubes for preparing PRP (The method of making PRP was taken from Sonnleitner D).
Implant insertion
The second phase of the experiment included early insertion of implants. Artificial per-implant bone defects were made around the implants' neck on the medial side of the implant. The horizontal size of the bone defects was 2 mm and their depth was 4 mm. A cylindrical BCT implant was placed into the extraction alveoli. The implant had 5 threads, a SLA surface, overall length of the neck and body was 17.5 mm, radius 4.5 mm in the neck and 3 mm in the body. The distance between the threads was 1.75 mm.
Immediately after placing the implant in the site the bone defects were filled, following the relevant protocol and using platelet-rich plasma produced from each animal one hour before the surgical intervention. A scheme of the arrangement of the inserted implants and filling of the bone defects is given in Figure 1 .
Guided bone regeneration was used for filling in the bone defects. It was done in the following way:
• With platelet-rich plasma (PRP) combined with bovine deproteinized bone (BDK) and resorbable 150 m thick membrane of bovine origin on the left side of the lower jaw in the extraction alveolus of the third premolar (Ld -left distal).
• With bovine deproteinized bone (BDK) and resorbable 150 m thick membrane of bovine origin (BDM) on the right side of the lower jaw in the extraction alveolus of the third premolar (Dd -right distal).
• With platelet-rich plasma (PRP) and resorbable 150 m thick membrane of bovine origin (BDM) on the left side of the lower jaw in the extraction alveolus of the second premolar (Lm -left medial).
• With resorbable 150 m thick membrane with bovine origin (BDM) on the right side of the lower jaw in the extraction alveolus of the second premolar (Dm, right medial).
This was followed by measuring initial stability of the inserted implants using Periotest.
Measuring implant mobility using Periotest
Immediately after placing the implants into their sites their mobility was measured. This was done using Periotest (Simens, Figure 2 ) with the standard scale of the Periotest values. A transepitelial extension was placed on the implant connection, which enabled appropriate measuring of implant mobility. The probe for measuring mobility had to be at a distance of 0.5-2.5 mm from the object that was measured. The angle between the probe and the axis of the measured implant was 90 o . Measuring was done three times for each implant. Once measuring was completed, a security screw was placed for the resting period. The implants were covered with a mucoperiosteal flap which was attached with separate closures.
The third phase of the experiment Ten weeks after implant insertion in the lower jaw the animals were put under anaesthesia in the same way as described for the first phase of the experiment. Measuring implant mobility was done in the same way as described for the second phase of the experiment. Table 2 contains main descriptors of separate samples with respect to dental implant stability in relation with the protocol was applied. Two teeth were extracted, II and III premolar, from the lower jaw of each dog followed by early insertion of dental implants. On each of the separate samples (size n =10) one of the described protocols of guided bone regeneration was applied. The graphs show histograms of the frequencies of the measured PTV for different protocols and basic descriptors of separate samples (arithmetic mean, standard deviation, and N -the number of bone defects in the sample). group "I". It means that this method provides better results than the others with respect to stability in early implant insertion. On the contrary, the worst results were recorded respectively with the sample that was treated according to the protocol "IV" -RBDM.
To see if there is a significant difference between the results of measuring implant mobility 10 weeks after insertion for the four applied protocols of guided bone regeneration, we applied analysis of variance (ANOVA). F score, F=V F /V R , F=1.995. The score is higher than 1 which in accord with the claim that the applied protocol differ with respect to their influence on implant stability. However, F score was lower than the critical value in the F score table of values. For a significance level of 0.5, with the degree of freedom of factor variance v 1 = 3 and the degree of freedom of residual variance v 2 =36 the critical value was We can see on the graphs of mean values and dispersion of values, in CI=95%, i. e. ± 2SD, that protocols I, II, and III have similar mean values and that they are more homogenous than protocol IV. This indicates smaller oscillations in implant mobility when these protocols are used. However, it should be noted that the mean values for all the protocols belong to the most quality group of implant stability -the "zero" group.
DISCUSSION
Increased implant mobility is a direct indicator of inadequate osseointegration. Lack of bone tissue in oral implantation can make supported prostheses and implant treatment impossible. This is why the mobility test is a specific diagnostic method of detecting lack of osseointegration and a key factor in making a decision whether to remove the involved implant or not. Periotest values are a reliable indicator of the mobility of dental implants. These values can serve as a basis for assessing the relation between an implant and bone (Olive et al., 1990) .
The Assessing implant mobility immediately after insertion and 3 months after immediate insertion into the extraction alveolus with dogs shows that high values of stability were achieved in all cases and all implants belong to the "zero" mobility group (mobility -8 to +9) and that, according to this, all the protocols provide satisfying results. Examination of statistical significance of the differences between the mean values of implant mobility 3 months after immediate insertion into the extraction alveolus according to the four protocols of guided bone regeneration showed that there is no significant difference between the protocols. Nevertheless, the best results were recorded with protocol I (PRP-BDK-RBDM, platelet-rich plasma + bovine deproteinized bone + resorbable membrane with bovine origin). The worst results of stability of dental implants are recorded with the sample where protocol IV (RBDM, resorbable membrane with bovine origin) was applied. Cune et al. (1996) point out that Periotest values for osseointegrated implants should not exceed the value of +3 and should be negative. Barber et al. (1996) used Periotest to compare osseointegated implants with and without healing abutments. The Periotest measurements were done immediately after insertion and 5 months after insertion. The results show that there is a big difference in the Pertiotest values (PTV) for implants immediately after insertion in comparison with implants 5 months after insertion. The values immediately after insertion are higher, in the range -0.7 to -0.4. The values 5 months after insertion are within the range -0.5 to -0.3. All the 50 Periotest values in this study were negative, which means decreasing mobility. The lower values for the measurement after 5 months can be explained by bone maturation, which reduces the negativity of PTV values. Rotter et al. (1996) used Periotest to examine patients with 26 implants, 15 of which were loaded progressively and 11 were left without load untitil final prosthetic restoration. All PTV in this study were about 0 index, meaning that there was no implant mobility. However, the value were different and an increased rigidity (higher negative values) could be noted with the implant that were progressively loaded. These results brought to the conclusion that submitting the implant to a limited force during the healing period can have positive effects on bone healing and extent of osseointegration.
Research of Ericsson et al. (1997) showed that, measured 5 years after insertion, implant stability is equal in both cases -with either one step and two step insertion techniques. PTV values were negative in both cases, ranging from -6 to +3 in the case of one step technique, while the interval was a little wider for the two step technique. Simunek et al. (2002) compared the stability of titanium implants and implants made of titanium and coated with hydroxyapatite. Using Periotest they got PTV values that indicate a more rigid connection of the hydroxyapatite-coated implants than it is the case of implants with a titanium surface. The PTV values were within the range -8 to +2 for both types of implants in the initial phase, with no statistical difference between the mean values for the two groups. One year after insertion the values were -2.30 for the hydroxyapatite-coated implants and -1.89 for the other group.
Using Periotest in measuring implant mobility in "in-vitro" conditions proved that it is a reliable indicator of bone loss around an implant (Lachmann et al., 2006) . However, Lachmann et al., (2006) keep some reserve in their conclusions, arguing that one should never rely on just one method in clinical testing.
On the basis of our research can be concluded that dental implant mobility is lowest for the protocol where platelet-rich plasma was used combined with bovine deproteinized bone and resorbable membrane of bovine origin.
Future research should be directed towards identifying different growths factors, examining their influence, and defining their optimal concentration in different protocols of dental implant insertion. Oseointegracija dentalnih implantata nastaje iz }elijske migracije, diferencijacije, ko{tane formacije i ko{tane remodelacije du`povr{ine implantata; svaki od ovih procesa je zavistan od trombocita i krvnog koaguluma. Plazma bogata trombocitima (PRP) se primenjuje da bi se pove}ala oseointegracija odnosno stabilnost implantata. To je frakcija krvi dobijena centrifugiranjem koja sadr`i visoke koncentracije trombocita. Trombociti sadr`e brojne faktore rasta poput PDGF, TGF-b, IGF, VEGF i druge koji doprinose tkivnim reakcijama. Cilj rada je bio da se klini~ki ispita uticaj plazme bogate trombocitima i vo|ene tkivne regeneracije u ko{tanim defektima kod rane ugradnje dentalnih impantata na pokretljivost dentalnih implantata. Eksperimentalna studija je sprovedena na 10 eksperimentalnih pasa kod kojih je ugra|eno 40 BCT implantata i to po 4 (dva sa leve strane i dva sa desne strane uz vo|enu tkivnu regeneraciju). Merenje pokretljivosti implantata vr{eno je neposredno nakon ugradnje i 10 nedelja nakon ugradnje aparatom Periotest. Rezultati merenja pokretljivosti implantata prema Periotestnim vrednostima su pokazali da se ugra|eni implantati u sve 4 grupe mogu svrstati u grupu 0 stepena pokretljivosti. Na osnovu dobijenih rezultata do{li smo do zaklju~ka da je pokretljivost dentalnih implantata najmanja u protokolu gde je primenjena plazma bogata trombocitima u kombinaciji sa bovinom deproteinizovanom kosti i resorptivnom membranom bovinog porekla.
